Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (371-380 of 13,978) with videos related to

Pageof 1,398
Sort By:
Leukemia|November 15, 2011
Nilotinib in patients with Ph+ chronic myeloid leukemia in accelerated phase following imatinib resistance or intolerance: 24-month follow-up resultsP D le Coutre, F J Giles, A Hochhaus, et al.
Leukemia|November 9, 2011
Oral high-dose glucocorticoids and ofatumumab in fludarabine-resistant chronic lymphocytic leukemiaD E Spaner
Leukemia|October 1, 1990
In vivo recruitment of GM-CSF-response myelopoietic progenitor cells by interleukin-3 in aplastic anemiaF Herrmann, A Lindemann, A Raghavachar, et al.
Leukemia|October 1, 1990
Association of protein tyrosine phosphorylation with B cell differentiation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA)H Kuratsune, M K Owada, Y Tokumine, et al.
Leukemia|October 12, 2011
Inhibition of Myb-dependent gene expression by the sesquiterpene lactone mexicanin-IT Bujnicki, C Wilczek, C Schomburg, et al.
Leukemia|October 12, 2011
Extreme telomere erosion in ATM-mutated and 11q-deleted CLL patients is independent of disease stageB Britt-Compton, T T Lin, G Ahmed, et al.
Leukemia|September 20, 2011
Significantly worse survival of patients with NIH-defined chronic graft-versus-host disease and thrombocytopenia or progressive onset type: results of a prospective studyZ Kuzmina, S Eder, A Böhm, et al.
Leukemia|September 20, 2011
Polymorphism of the erythropoietin gene promotor and the development of myelodysplastic syndromes subsequent to multiple myelomaO Landgren, W Ma, R A Kyle, et al.
Leukemia|December 23, 2011
BCL2 mutations in diffuse large B-cell lymphomaJ M Schuetz, N A Johnson, R D Morin, et al.
Leukemia|May 29, 2009
Class effects of tyrosine kinase inhibitors in the treatment of chronic myeloid leukemiaF J Giles, M O'Dwyer, R Swords
Pageof 1,398

Showing results (371-380 of 13,978) with videos related to

Sort By:
Pageof 1,398
Leukemia|November 15, 2011
Nilotinib in patients with Ph+ chronic myeloid leukemia in accelerated phase following imatinib resistance or intolerance: 24-month follow-up resultsP D le Coutre, F J Giles, A Hochhaus, et al.
Leukemia|November 9, 2011
Oral high-dose glucocorticoids and ofatumumab in fludarabine-resistant chronic lymphocytic leukemiaD E Spaner
Leukemia|October 1, 1990
In vivo recruitment of GM-CSF-response myelopoietic progenitor cells by interleukin-3 in aplastic anemiaF Herrmann, A Lindemann, A Raghavachar, et al.
Leukemia|October 1, 1990
Association of protein tyrosine phosphorylation with B cell differentiation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA)H Kuratsune, M K Owada, Y Tokumine, et al.
Leukemia|October 12, 2011
Inhibition of Myb-dependent gene expression by the sesquiterpene lactone mexicanin-IT Bujnicki, C Wilczek, C Schomburg, et al.
Leukemia|October 12, 2011
Extreme telomere erosion in ATM-mutated and 11q-deleted CLL patients is independent of disease stageB Britt-Compton, T T Lin, G Ahmed, et al.
Leukemia|September 20, 2011
Significantly worse survival of patients with NIH-defined chronic graft-versus-host disease and thrombocytopenia or progressive onset type: results of a prospective studyZ Kuzmina, S Eder, A Böhm, et al.
Leukemia|September 20, 2011
Polymorphism of the erythropoietin gene promotor and the development of myelodysplastic syndromes subsequent to multiple myelomaO Landgren, W Ma, R A Kyle, et al.
Leukemia|December 23, 2011
BCL2 mutations in diffuse large B-cell lymphomaJ M Schuetz, N A Johnson, R D Morin, et al.
Leukemia|May 29, 2009
Class effects of tyrosine kinase inhibitors in the treatment of chronic myeloid leukemiaF J Giles, M O'Dwyer, R Swords
Pageof 1,398